Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Roche NimbleGen CNV arrays selected for landmark Korean copy number variation study
August 2009
SHARING OPTIONS:

MADISON, Wis.Roche NimbleGen has entered into a partnership with the Korea Centers for Disease Control and Prevention (KCDC) and Macrogen Inc. to conduct an eight-month intensive copy number variation (CNV) study of Korean individuals. The new, two-phased CNV study is an extension of the Korean Association Resource (KARE) project that has been focused on identifying single nucleotide polymorphism (SNP) associations with various diseases, including diabetes. This study will include large-scale characterization of CNVs in Korean populations and analysis of common CNVs in genome-wide association studies for complex diseases, including diabetes. According to the companies, the study's results could broaden the population spectrum of CNV data in existing databases and provide new insights into the contribution of CNVs to normal phenotypic variation, disease susceptibility and response to drug therapies.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.